Introduction

Electrical conduction within the heart is a finely tuned system that ensures efficient pumping function. Among the vital components of this conduction system are the bundle branches and their respective fascicles, responsible for distributing electrical impulses to the ventricles. Disruptions to these fascicles can present as various conduction blocks detectable on electrocardiograms (ECGs). One sporadic form is the Isolated Left Posterior Fascicular Block (LPFB). Even less understood is how this singular condition compares with Combined Fascicular Blocks, including bifascicular and trifascicular patterns. Understanding these distinctions is crucial, as they bear different prognostic and management implications. This article will comprehensively explore both conditions, detailing their clinical features, aetiology, diagnostic approach, treatment options, prognosis, and frequently asked questions, helping clinicians and medical students appreciate their nuances.¹

Anatomy and conduction physiology

The heart's conduction system includes the sinoatrial node, atrioventricular (AV) node, bundle of His, and the bundle branches. The left bundle branch bifurcates into two main fascicles:

• Left Anterior Fascicle (LAF)
• Left Posterior Fascicle (LPF)

The Right Bundle Branch (RBB) completes the trifascicular system. The left anterior fascicle travels to the anterolateral wall of the left ventricle, while the left posterior fascicle innervates the posteroinferior branch.²

Disruption of any one of these fascicles impedes impulse conduction, altering the sequence and direction of ventricular depolarisation. Such disruptions manifest on ECG as axis deviations and particular QRS morphologies.³

Clinical features

Isolated LPFB

• ECG Characteristics:
  • Right-axis deviation (+90 to +180 degrees)
  • rS complex in leads I and aVL
  • qR complex in leads II, III, and aVF
  • Normal or slightly prolonged QRS (<120 ms)
  • Absence of right ventricular hypertrophy, pulmonary disease, or other causes of right-axis deviation⁴
• Symptoms:
  • Usually asymptomatic
  • May mask an inferior myocardial infarction
  • Rarely presents with palpitations or dizziness⁵

Combined fascicular blocks

• Types:
  • Bifascicular Block: Right bundle branch block (RBBB) + left anterior fascicular block (LAFB) or RBBB + left posterior fascicular block (LPFB)
  • Trifascicular Block: RBBB + LAFB + AV block (1st or 2nd degree)⁶
• ECG Characteristics:
  • RBBB: rsR' pattern in V1-V2, wide S wave in I and V6
  • LAFB: left axis deviation, small q in I and aVL, rS in II, III, aVF
  • LPFB: right axis deviation with the aforementioned LPFB pattern
  • PR interval prolongation in trifascicular blocks⁷
• Symptoms:
  • Syncope
  • Presyncope
  • Fatigue or palpitations
  • Risk of complete AV block in symptomatic cases⁸

Etiology

Isolated LPFB

Isolated LPFB is often secondary to localised damage of the left posterior fascicle. Key etiologies include:

• Ischemic Heart Disease:
  • Most commonly due to an inferior wall myocardial infarction affecting the left posterior fascicle
  • Multi-vessel coronary artery disease may also contribute
• Degenerative Conduction System Disease:
  • Lenègre’s disease: idiopathic fibrosis of the conduction system in younger patients
  • Lev’s disease: age-related sclerodegenerative changes are more common in the elderly
• Cardiomyopathies:
  • Including dilated or ischemic cardiomyopathy that alters conduction pathways through myocardial remodeling
• Post-surgical or Iatrogenic Injury:
  • Valve replacements or septal defect repairs may disrupt conduction fibers
• Inflammatory and Infiltrative Diseases:
  • Sarcoidosis, amyloidosis, and myocarditis can infiltrate or scar conduction tissue¹⁰

Combined fascicular blocks

These blocks usually arise from more diffuse or severe pathologies, including:

• Extensive Myocardial Infarction (MI):
  • Anterior MI: affects both RBB and LAF
  • Inferior MI: may involve LPF
• Aortic Valve Disease:
  • Aortic stenosis can compress or calcify adjacent conduction pathways
• Hypertrophic Cardiomyopathy:
  • Especially with interventricular septal hypertrophy
• Congenital Heart Conditions:
  • Like Tetralogy of Fallot or VSD repair history
• Drug Effects and Electrolyte Abnormalities:
  • AV-nodal blocking agents (e.g., digoxin, beta-blockers), hyperkalemia

Diagnostic approach

An effective diagnostic strategy involves a stepwise approach:

1. Electrocardiogram (ECG):
   • Analyse axis deviation, QRS duration, and morphology
   • Look for PR interval prolongation.
2. Detailed Clinical History and Physical Examination:
   • Syncope, dizziness, chest pain, or medication history
3. Laboratory Evaluation:
   • Electrolyte levels, cardiac biomarkers, and inflammatory markers
4. Echocardiography:
   • Identify structural abnormalities (e.g., septal hypertrophy, valve lesions)
5. Holter Monitor or Event Recorder:
   • Detect intermittent blocks or pauses, particularly in symptomatic patients.
6. Electrophysiological Study (EPS):
   • Useful in assessing conduction delay and determining pacemaker need, especially in bifascicular or trifascicular blocks with syncope
7. Advanced Imaging:
   • Cardiac MRI or PET for inflammatory or infiltrative causes (e.g., sarcoidosis, amyloidosis)

Management

Isolated LPFB

• Observation:
  • No treatment is necessary for asymptomatic, incidental LPFB
• Treat Underlying Causes:
  • Revascularisation in ischemic heart disease
  • Anti-inflammatory treatment for myocarditis or infiltrative diseases
• Monitoring:
  • Serial ECGs to monitor progression
  • Holter monitoring in symptomatic individuals
• Electrophysiological Testing:
  • For unclear symptoms or suspected progression

Combined fascicular blocks

• Asymptomatic Patients:
  • Monitor with regular ECGs and clinical follow-up
  • Discontinue or adjust medications contributing to the block
• Symptomatic Patients (e.g., syncope):
  • Class I indication for a permanent pacemaker.
  • Consider hospitalisation for monitoring in high-risk individuals
• Trifascicular Blocks:
  • A permanent pacemaker is usually required
  • Evaluate for reversible causes (e.g., ischemia, drug toxicity)
• EPS-guided Therapy:
  • Helps determine pacing need in ambiguous cases
• Comorbid Disease Management:
  • Optimise treatment of heart failure, ischemia, or valve disease

Prognosis

Isolated LPFB

• Benign Course:
  • Most patients remain stable
  • Rarely progresses to more advanced blocks unless associated with structural disease
• Risk Marker:
  • May indicate previous inferior MI
  • Prognostic implications depend on the underlying etiology

Combined fascicular blocks

• Variable Prognosis:
  • Asymptomatic bifascicular blocks may remain stable for years.
  • Symptomatic cases carry a higher risk of complete AV block.
• Pacemaker Improves Outcomes:
  • Reduces risk of syncope, bradyarrhythmias, and sudden death.
• Ongoing Follow-up:
  • ECG, echocardiography, and possibly advanced imaging.
  • Tailor frequency based on the symptom

FAQs

1. How rare is isolated LPFB?
   • Extremely rare, accounting for less than 0.1% of ECGs
2. Does LPFB require treatment?
   • No, unless there are underlying conditions or symptoms
3. Can LPFB mask a heart attack?
   • Yes, especially inferior MI may be obscured on ECG
4. What is the most common combined fascicular block?
   • RBBB with LAFB
5. When should a pacemaker be implanted?
   • In symptomatic patients or if an advanced AV block is documented
6. Are fascicular blocks reversible?
   • Some may be transient if due to reversible causes (e.g., drugs, ischemia)
7. Do all patients with trifascicular block need pacing?
   • Most do, especially if there's PR prolongation or symptoms
8. Can exercise worsen fascicular blocks?
   • It can unmask or aggravate conduction delays in some patients
9. Is LPFB hereditary?
   • No clear genetic link has been established
10. How should patients with fascicular blocks be followed?
    • Regular ECG monitoring, symptom surveillance, and annual follow-ups

Summary

Understanding the differences between isolated LPFB and combined fascicular blocks is essential for accurate diagnosis and appropriate management. At the same time, isolated LPFB is usually benign and requires minimal intervention, combined fascicular blocks—especially when symptomatic—necessitate a more aggressive approach, including monitoring and potential pacemaker implantation. The key lies in vigilant ECG interpretation, identification of underlying diseases, and personalised risk stratification. In clinical practice, the presence of fascicular blocks should prompt a comprehensive cardiovascular evaluation to ensure optimal patient outcomes.